Description

Vyvanse (Lisdexamfetamine Dimesylate)

Vyvanse (lisdexamfetamine dimesylate) is a prescription central nervous system (CNS) stimulant used primarily for the treatment of attention-deficit/hyperactivity disorder (ADHD). It is an orally administered medication and is classified as a Schedule II controlled substance in the United States.

Vyvanse Medication Information

Category	Information
Active Ingredient	Lisdexamfetamine dimesylate
Availability	Prescription only
Therapeutic Class	Central nervous system (CNS) stimulant
Administration	Oral
Controlled Status	Schedule II (C-II) controlled substance
Primary Therapeutic Use	Attention-deficit/hyperactivity disorder (ADHD)

Available Forms

Capsules

Vyvanse capsules are available in several strengths. Depending on the specific product and prescribing information, capsule strengths include:

• 10 mg
• 20 mg
• 30 mg
• 40 mg
• 50 mg
• 60 mg

What Is Vyvanse (Lisdexamfetamine Dimesylate)?

Vyvanse is a CNS stimulant containing the active ingredient lisdexamfetamine dimesylate. It is a prodrug that is converted in the body to dextroamphetamine. The resulting stimulant activity affects neurotransmitter systems involved in attention and impulse control.

The precise mechanism by which Vyvanse produces its therapeutic effects in ADHD is not completely understood. Its pharmacological activity involves the central nervous system and neurotransmitters including dopamine and norepinephrine.

Therapeutic Uses

Vyvanse is approved for the treatment of ADHD in adults and children aged 6 years and older. Treatment should be individualized by a qualified healthcare professional based on the patient’s medical history, symptoms, age, and response to therapy.

Commonly Associated Brand and Medication Names

Lisdexamfetamine is distinct from other stimulant medications, even though several prescription products belong to the broader CNS stimulant category. Names sometimes encountered in discussions of prescription stimulants include Adzenys ER, Desoxyn, Dyanavel, Evekeo, Vyvanse, and Zenzedi. These medications contain different active ingredients and should not be considered interchangeable solely because they belong to the same therapeutic class.

Administration

Vyvanse is administered orally. The appropriate dose and administration schedule are determined by the prescribing healthcare professional. Patients should follow the prescription label and official medication instructions rather than changing the dose or frequency independently.

Important Safety Information

Because Vyvanse is a prescription CNS stimulant and controlled substance, it should only be used by the person for whom it was prescribed. Taking the medication differently from the prescribed directions or using someone else’s prescription can result in serious health risks.

• Use only as directed by a qualified healthcare professional.
• Do not share prescription stimulant medication with another person.
• Tell your healthcare professional about other medications, supplements, and medical conditions before treatment.
• Store the medication securely and according to the product’s storage instructions.
• Contact a healthcare professional if you experience concerning or unexpected symptoms.

Frequently Asked Questions

What is Vyvanse used for?

Vyvanse is primarily prescribed for the treatment of ADHD in adults and children aged 6 years and older.

Is Vyvanse prescription only?

Yes. Vyvanse is a prescription medication and is classified as a Schedule II controlled substance in the United States.

How is Vyvanse administered?

Vyvanse is administered orally and is available in capsule and chewable tablet formulations.

What is the active ingredient in Vyvanse?

The active ingredient is lisdexamfetamine dimesylate.